Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(38 sites)

United States

Onyx Clinical Research, Peoria, Arizona

Exinia Research, La Mesa, California

Evergreen Clinical Trial, Norcross, Georgia

Bioluminux Clinical Research, Naperville, Illinois

Exinia Research, Des Moines, Iowa